Evidence map›Paper›PMID 23629648›Full record

ArticleThe Journal of biological chemistry2013

Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells.

Rabia U Malik, Michael Ritt, Brian T DeVree, Richard R Neubig, Roger K Sunahara, Sivaraj Sivaramakrishnan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Future Directions in GPCR Biased Signaling and Ligand Pharmacology.Handbook of experimental pharmacology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. In silico identification of a βProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Genetically encoded fluorescent biosensors for GPCR research.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rabia U MalikDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Michael Ritt
Brian T DeVree
Richard R Neubig
Roger K Sunahara
Sivaraj Sivaramakrishnan
University of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although several recent studies have reported that GPCRs adopt multiple conformations, it remains unclear how subtle conformational changes are translated into divergent downstream responses. In this study, we report on a novel class of FRET-based sensors that can detect the ligand/mutagenic stabilization of GPCR conformations that promote interactions with G proteins in live cells. These sensors rely on the well characterized interaction between a GPCR and the C terminus of a Gα subunit. We use these sensors to elucidate the influence of the highly conserved (E/D)RY motif on GPCR conformation. Specifically, Glu/Asp but not Arg mutants of the (E/D)RY motif are known to enhance basal GPCR signaling. Hence, it is unclear whether ionic interactions formed by the (E/D)RY motif (ionic lock) are necessary to stabilize basal GPCR states. We find that mutagenesis of the β2-AR (E/D)RY ionic lock enhances interaction with Gs. However, only Glu/Asp but not Arg mutants increase G protein activation. In contrast, mutagenesis of the opsin (E/D)RY ionic lock does not alter its interaction with transducin. Instead, opsin-specific ionic interactions centered on residue Lys-296 are both necessary and sufficient to promote interactions with transducin. Effective suppression of β2-AR basal activity by inverse agonist ICI 118,551 requires ionic interactions formed by the (E/D)RY motif. In contrast, the inverse agonist metoprolol suppresses interactions with Gs and promotes Gi binding, with concomitant pertussis toxin-sensitive inhibition of adenylyl cyclase activity. Taken together, these studies validate the use of the new FRET sensors while revealing distinct structural mechanisms for ligand-dependent GPCR function.

Indexed as

Adrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsAmino Acid MotifsAmino Acid SubstitutionCyclic AMPFluorescence Resonance Energy TransferGTP-Binding Protein alpha SubunitsGuanosine 5'-O-(3-Thiotriphosphate)HEK293 CellsHumansMetoprololModels, MolecularMutagenesis, Site-DirectedOpsinsPeptide FragmentsPropanolaminesAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsCyclic AMPGTP-Binding Protein alpha SubunitsGuanosine 5'-O-(3-Thiotriphosphate)ICI 118551MetoprololOpsinsPeptide FragmentsPropanolaminesReceptors, Adrenergic, beta-2Receptors, G-Protein-CoupledRecombinant Fusion Proteins7-Helix ReceptorCell Signaling(E/D)RY MotifFretFunctional SelectivityG Protein-coupled Receptors (GPCR)G Proteins

Identifiers

PMID23629648
PMCPMC3682522
OpenAlexW2168433979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.